David Ott Net Worth & Insider Trades

David Ott Zentalis Pharmaceuticals, Inc

As of December 3, 2020

What is David Ott's Net Worth?

The current estimated net worth of Zentalis Pharmaceuticals, Inc's David Ott is estimated to be about $14.06B . David Ott owns about 3,943,284 units of Zentalis Pharmaceuticals, Inc common stock. In the last 9 months at Zentalis Pharmaceuticals, Inc, David Ott has sold an estimated value of $25.25M worth.

What is David Ott's Past Insider Trading?

David Ott's largest purchase order was 725,000 units , worth over $13.05M on April 8, 2020. David Ott's largest sale order was 500,000 units , worth over $25.25M on December 3, 2020. In total, David Ott has made about 2 transactions over 9 months of their time at Zentalis Pharmaceuticals, Inc. David Ott usually trades in December and April, with the busiest year in 2020.

VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Illiquid Investments SubMaster LP, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities GP LLC, ANDREAS OLE HALVORSEN, David Ott, Sharon Rose Shabet

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Ott's' Mailing Address?

  • Mailing address is C/o Viking Global Investors Lp 280 Park Avenue New York NY 10017 NY

Zentalis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony Sun, M.D. 2020 $561,232 - $8,100,645 $5,986,469 $287,375 $108,678 $15,044,399
Anthony Sun, M.D. 2019 $455,091 - - $918,000 $204,971 - $1,577,882
Kevin Bunker, Ph.D. 2020 $428,771 - $2,580,864 $2,993,235 $179,550 $91,174 $6,273,594
Kevin Bunker, Ph.D. 2019 $360,024 - - $275,400 $144,010 - $779,434
Alexis M. Pinto 2020 $136,923 - - $6,234,468 $152,000 $10,511 $6,533,902
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1725160/000172516021000099/proxystatement-2021.htm

What are Zentalis Pharmaceuticals, Inc's Past Insider Trades?

Zentalis Pharmaceuticals, Inc's most recent insider trade came on November 15, 2022 by Cam Gallagher who sold 12,500 units worth $284.68K . In the last 2 years, insiders at Zentalis Pharmaceuticals, Inc have sold an estimated value of $106.78M and bought an estimated value of $15.77M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Kevin D Bunker, Chief Scientific Officer,  Cam Gallagher, President,  and Anthony ySun, President & CEO .

Zentalis Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1